Measurable residual disease in haematological and solid cancers
Roland B Walter1,2,3, Robert Peter Gale4
1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. rwalter@fredhutch.org.
Leukemia
|June 27, 2024
Summary
No abstract available in PubMed .
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.3K
